lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

The Clinical Impact and Cost Effectiveness of Intervention Policies Against the SARS-CoV-2 Pandemic: A Mathematical Modelling Analysis

26 Pages Posted: 25 Aug 2021

See all articles by Bin Wu

Bin Wu

Shanghai Jiao Tong University (SJTU) - Medical Decision and Economic Group

Yuetian Yu

Shanghai Jiao Tong University (SJTU)

Xinglin Feng

Peking University - Department of Health Policy and Management

More...

Abstract

Background: To investigate the clinical and economic outcomes, of intervention policies combining nonpharmaceutical interventions and vaccination programs for dealing with the SARS-CoV-2 pandemic.  

Methods: An agent-based model transmission model was adopted which describes how a SARS-CoV-2 virus will spread in the populations of China. The model inputs were derived from literature and expert opinion. The following intervention policies were simulated: no intervention, strict nonpharmaceutical interventions, nonpharmaceutical intervention for workplace, community, school and home gradually dismissed by combining vaccination programs in pre-specified age groups. The cumulative infection and death in one calendar year, costs and quality adjusted life years (QALYs) were measured.  

Findings: When the vaccination program had been at least taken up in ≥20 years and all populations, nonpharmaceutical intervention for workplace and community settings could be gradually dismissed because the cumulative number of infections was < 100 per 100,000 persons. Further dismissing nonpharmaceutical intervention for school and home settings could not meet the target even when the vaccination program had been taken up in all populations. When cumulative death was used as the endpoint, nonpharmaceutical intervention in workplace, community and school settings could be gradually dismissed. Vaccine efficacy and coverage have substantial impacts. Dismissing nonpharmaceutical interventions in workplace settings could produce the lowest cost when vaccination programs are at least taken up at age ≥10 years, which also dominates most intervention strategies due to its lower costs and higher QALYs.  

Interpretation: Continued nonpharmaceutical interventions might be gradually dismissed until herd immunity is achieved.  

Funding: None to declare.

Declaration of Interest: None to declare.

Suggested Citation

Wu, Bin and Yu, Yuetian and Feng, Xinglin, The Clinical Impact and Cost Effectiveness of Intervention Policies Against the SARS-CoV-2 Pandemic: A Mathematical Modelling Analysis (8/24/2021). Available at SSRN: https://ssrn.com/abstract=3911364 or http://dx.doi.org/10.2139/ssrn.3911364

Bin Wu (Contact Author)

Shanghai Jiao Tong University (SJTU) - Medical Decision and Economic Group ( email )

Shanghai
China

Yuetian Yu

Shanghai Jiao Tong University (SJTU) ( email )

KoGuan Law School
Shanghai 200030, Shanghai 200052
China

Xinglin Feng

Peking University - Department of Health Policy and Management ( email )

Beijing
China

Click here to go to TheLancet.com

Paper statistics

Downloads
38
Abstract Views
240
PlumX Metrics